secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001161697-24-000335
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q2 revenue record $8.4M, up 22%; raises FY2024 guidance
--------------------------------------------------------------------

- Q2 net revenues of $8.4M, a 22% YoY increase; core business grew 20% driven by SCIg market growth and share gains.
- Gross margin expanded to 65% from 56.1% YoY, a 890bps improvement; gross profit up 41% to $5.5M.
- Net loss improved to $1.0M ($0.02 per share) from $2.5M loss ($0.05 per share) in Q2 2023; adjusted EBITDA loss narrowed to $0.4M.
- Raised FY2024 revenue guidance to $32.0-$32.5M (12-14% growth) and gross margin guidance to 61-62%.
- Cash balance $10.5M; quarterly cash usage $0.3M; reaffirmed cash flow breakeven in Q4 2024 and positive cash in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169724000335/0001161697-24-000335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169724000335/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-24-000335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer